ChakerL, PapaleontiouM. Hypothyroidism: A review. JAMA. Epub2025; doi: 10.1001/jama.2025.13559.
2.
RodondiN, den ElzenWP, BauerDC, et al.Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA2010;304(12):1365-1374; doi: 10.1001/jama.2010.1361.
3.
RazviS, ShakoorA, VanderpumpM, WeaverJU, PearceSH. The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: A metaanalysis. J Clin Endocrinol Metab2008;93(8):2998-3007; doi: 10.1210/jc.2008-0167.
4.
ZijlstraLE, JukemaJW, WestendorpRGJ, et al.Levothyroxine treatment and cardiovascular outcomes in older people with subclinical hypothyroidism: Pooled individual results of two randomised controlled trials. Front Endocrinol (Lausanne)2021;12:674841; doi: 10.3389/fendo.2021.674841.
5.
RazviS, WeaverJU, ButlerTJ, PearceSH. Levothyroxine treatment of subclinical hypothyroidism, fatal and nonfatal cardiovascular events, and mortality. Arch Intern Med2012;172(10):811-817; doi: 10.1001/archinternmed.2012.1159.
6.
RanX, WangN, ZhaoT, FanZ, ChenG, MaX. Hypothyroidism and risks of all-cause and cardiovascular mortality: A retrospective cohort study of 70,276 Chinese adults. Thyroid2025;35(12):1403-1411; doi: 10.1177/10507256251393523.
7.
KotwalA, CortesT, GenereN, et al.Treatment of thyroid dysfunction and serum lipids: A systematic review and meta-analysis. J Clin Endocrinol Metab2020;105(12):dgaa672; doi: 10.1210/clinem/dgaa672.